What are the side effects of Inluriyo (Imlunestrant)?

Inluriyo (Imlunestrant) is a newly launched drug designed to treat patients with estrogen receptor-positive (ER+), human epidermal growth factor receptor 2-negative (HER2-), and ESR1-mutated advanced or metastatic breast cancer. Patients need to be aware of possible side effects and precautions when using Inluriyo.

One of the most concerning warnings when using Inluriyo is the potential for embryo-fetal toxicity. Therefore, during treatment, female patients should take strict contraceptive measures to avoid using this drug during pregnancy.

Common adverse reactions occur in 10% or more of and include musculoskeletal pain, fatigue, diarrhea, nausea, constipation and abdominal pain. These adverse reactions may affect the patient's quality of life. Therefore, during the medication process, patients should regularly feedback their physical conditions to the doctor so that timely treatment and adjustment of the treatment plan can be achieved.

In addition,The use of Inluriyo may cause some laboratory abnormalities. During clinical monitoring, common laboratory abnormalities include decreased hemoglobin, decreased calcium, neutropenia, increased liver enzymes (AST and ALT), increased triglycerides, decreased platelets, and increased cholesterol. Changes in these laboratory indicators may reflect the effects of medications on the body and require regular testing to ensure patient safety.

In summary,As a treatment option for specific types of breast cancer, Inluriyo’s side effects and potential risks must be taken seriously. Patients should pay close attention to their health conditions while using this drug and communicate with the medical team in time if any discomfort occurs so that necessary measures can be taken. Through reasonable monitoring and management, adverse reactions can be alleviated to a certain extent, treatment effects can be improved, and patients can be provided with a better treatment experience.

Reference materials:https://www.drugs.com/inluriyo.html